Covestor’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Covestor’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-106	Closed	–	–	2923
2024 Q2	$0	Hold	106	–	–	﹤0.01%	2911
2024 Q1	$2K	Hold	106	–	–	﹤0.01%	1881
2023 Q4	$1K	Buy	106 +19	+22%	+$240	﹤0.01%	2071
2023 Q3	$1K	Hold	87	–	–	﹤0.01%	2037
2023 Q2	$1K	Buy	+87	New	+$1.09K	﹤0.01%	2053

Covestor's MACK Position: Q3 2024 in Review

Covestor sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2024, closing a stake of 106 shares.

Covestor first reported a position in MACK in Q2 2023 and held it in 5 quarters. The position peaked at $2K in Q1 2024. 2 funds tracked by Wall St. Rank hold MACK as of Q3 2024.

Covestor reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
Covestor sold 106 Merrimack Pharmaceuticals, Inc. shares in Q3 2024.
Covestor first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2023 and held it in 5 quarters.
Covestor's Merrimack Pharmaceuticals, Inc. position peaked at $2K in Q1 2024.
2 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2024.

Based on Covestor's 13F filing for Q3 2024, filed 1 Nov 2024.